Vivo Opportunity Fund Holdings, 10% Owner: Soleno Therapeutics SLNO Sell · Filed 25/03/28

Trade details

Type: Insider sale
Amount: $74,580,000
Shares · price: 1,100,000 sh · $67.80 a share
Held after: 4,791,851 sh
Stock: Soleno Therapeutics SLNO
Person: Vivo Opportunity Fund Holdings10% Owner
Trade date: 25/03/27
Filed: 25/03/28
Days to filing: 1 days

Sold 18.7% of holdings

Share of holding sold: 18.7%

Soleno Therapeutics trades, last 26 weeks

What else happened in Soleno Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/25~25/04/26

Vivo Opportunity Fund Holdings's recent trades

Vivo Opportunity Fund HoldingsDirector
Planned saleUnicycive Therapeutics
Planned sale
Unicycive Therapeutics
UNCY
$9.5M
1,789,916 sh
$9.5M
Filed 07/01
Traded 06/30
Vivo Opportunity Fund Holdings10% Owner
BuyInMed Pharmaceuticals
Buy
InMed Pharmaceuticals
INM
$79.6K
51,056 sh
$79.6K
Filed 06/10
Traded 05/20
Vivo Opportunity Fund Holdings10% Owner
BuyInMed Pharmaceuticals
Buy
InMed Pharmaceuticals
INM
$78.4K
49,966 sh
$78.4K
Filed 06/10
Traded 06/05
Vivo Opportunity Fund Holdings10% Owner
BuyInMed Pharmaceuticals
Buy
InMed Pharmaceuticals
INM
$52.2K
30,882 sh
$52.2K
Filed 06/10
Traded 05/21
Vivo Opportunity Fund Holdings10% Owner
BuyInMed Pharmaceuticals
Buy
InMed Pharmaceuticals
INM
$44.9K
29,518 sh
$44.9K
Filed 06/10
Traded 06/08